Posts by Marcela G. del Carmen, MD, MPH
-
Comprehensive Lymphadenectomy Often Not Necessary in Surgical Management of Primary Endometrioid Ovarian Carcinoma
Varvara Mazina, MD, Marcela G. del Carmen, MD, MPH, and colleagues showed in a retrospective cohort of 63 women with primary endometrioid ovarian cancer that all pelvic and para-aortic lymph nodes removed were negative for carcinoma and comprehensive cancer staging had no effect on progression-free or overall survival.
-
Lymph Node Evaluation Underutilized for Early-stage Vulvar Cancer
Massachusetts General Hospital researchers found in a nationwide study that contrary to guidelines, 34% of eligible patients with early-stage vulvar cancer did not undergo lymph node evaluation. Among patients 80 and older, the figure was 49%, even though withholding lymph node assessment did not improve survival.
-
Review: Lesions of the Ovary and Fallopian Tube
Rachel C. Sisodia, MD, and Marcela G. del Carmen, MD, MPH, emphasize that all patients with a high-risk lesion of the ovary or fallopian tube should be referred to a gynecologic oncologist, as multiple studies have shown comprehensive surgical staging and tumor debulking is associated with improved overall survival.
-
U.S. COVID-19 Test Results Strongly Correlate with Race/Ethnicity, Income
By reviewing data on 394,536 people tested for COVID-19 before vaccines became available, physicians at Massachusetts General Hospital confirmed that among tested patients, low-income patients and people of color in the US are more likely to have been infected.
-
How Research Has Impacted Care for Cervical Cancer video
In this video, Marcela del Carmen, MD, a gynecologic oncologist in the Department of Obstetrics and Gynecology at Massachusetts General Hospital, discusses how clinical care led to research and ultimately informed surgical approaches to cervical cancer.
-
Changing Treatment Paradigms in Gynecologic Oncology
In this video, Marcela del Carmen, MD, a gynecologic oncologist in the Department of Obstetrics and Gynecology at the Massachusetts General Hospital and Mass General Cancer Center, discusses an exciting innovation in the field: a platform called Patient-Reported Outcome Metrics.
-
Disparities in Gynecological Cancer Care
In this video, Marcela del Carmen, MD, a gynecologic oncologist and gynecologic surgeon at Massachusetts General Hospital, and chief medical officer of Massachusetts General Physicians Organization, discusses her research of the disparities in gynecological cancer care.
-
Editorial: It's Time to Study "Hospital at Home" After Surgery
Hospital at home may be a safe, less costly alternative to inpatient hospitalization for surgical patients.
-
Risk of Death After Cytoreduction of Advanced Ovarian Cancer Differs by Age
Gynecologic oncologists suggest neoadjuvant chemotherapy and interval cytoreduction for older women with advanced ovarian cancer.
-
Minimally Invasive Surgery Linked to Shorter Survival in Early-Stage Cervical Cancer
Among women with early-stage cervical cancer who undergo radical hysterectomy, survival after minimally invasive surgery is significantly shorter than after open surgery, according to the largest-ever investigation of this question.
Biography
Marcela G. del Carmen, MD, MPH, is a graduate of the Johns Hopkins School of Medicine. She completed a residency in gynecology and obstetrics at Johns Hopkins Hospital and a fellowship in gynecologic oncology at Massachusetts General Hospital. She graduated with a Masters in Public Health from the Harvard School of Public Health. Dr. del Carmen was on the faculty at Johns Hopkins before returning to join the faculty at Massachusetts General Hospital. Dr. del Carmen is board certified in Obstetrics and Gynecology and Gynecologic Oncology. Dr. del Carmen is an professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Dr. del Carmen is also Chief Medical Officer of the Massachusetts General Physicians Organization.
She is a fellow of the American College of Obstetricians and Gynecologists and the American College of Surgeons, and a full member of the Society of Gynecologic Oncology, the International Gynecologic Cancer Society, and the New England Society of Gynecologic Oncologists. Dr. del Carmen has been a member of the Ovarian Cancer Committee of the Gynecologic Oncology Group and currently serves on several committees in the Society of Gynecologic Oncologists.
Dr. del Carmen's research interests include the surgical treatment of gynecologic malignancies, specifically ovarian cancer, the management of rare gynecologic tumors and improving access to health care services for underserved populations. Dr. del Carmen has been a principal investigator of clinical trials evaluating novel therapies in the treatment of ovarian cancer, as well as the design of a novel device for delivery of intra-peritoneal catheter.
Dr. del Carmen has authored over 160 papers in the peer-reviewed literature and authored a textbook.
Mass General Center for Gynecologic Oncology
The Center for Gynecologic Oncology offers women comprehensive care supported by surgical innovation, research and clinical trials in all types and stages of gyn cancer, including cervical, endometrial, ovarian, uterine, vaginal and vulvar.
